Open AccessSynthesis and Pharmacological Characterization of Visabron, a Backbone Cyclic Peptide Dual Antagonist of α4β1 (VLA-4)/α9β1 Integrin for Therapy of Multiple Sclerosis
Author(s) -
Chaim Gilon,
Michal Klazas,
Adi Lahiani,
Adi SchumacherKlinger,
Shira Merzbach,
Johnny N Naoum,
Haim Ovadia,
Limor Rubin,
Susan Cornell-Ken,
Erik Schaefer,
Jehoshua Katzhendler,
Cezary Marcinkiewicz,
Am Hoffman,
Philip Lazarovici
Publication year - 2021
Publication title -
jacs au
Language(s) - English
Resource type - Journals
ISSN - 2691-3704
DOI - 10.1021/jacsau.1c00496
Subject(s) - disintegrin , peptidomimetic , pharmacology , immunogenicity , immunology , experimental autoimmune encephalomyelitis , monoclonal antibody , medicine , multiple sclerosis , chemistry , cancer research , antibody , peptide , biochemistry , metalloproteinase , matrix metalloproteinase
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom